MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Factitious Disorder Imposed on Another mimicking a Dopamine Dysregulation Syndrome

DRC. Carneiro, MS. Sousa, ASM. Morgadinho, CJ. Januário (Coimbra, Portugal)

Meeting: 2019 International Congress

Abstract Number: 363

Keywords: Dopamine dysregulation syndrome

Session Information

Date: Monday, September 23, 2019

Session Title: Psychiatric Manifestations

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To present a new type of Dopamine Dysregulation Syndrome in Parkinson’s Disease.

Background: Dopamine Dysregulation Syndrome (DDS) is a rare neuropsychiatric complication of Parkinson’s Disease (PD) therapy. In Factitious Disorder Imposed on Another (FDIA) someone fabricates or exaggerates features of a disease in another person.

Method: Case Report

Results: We present a case of a 70 year-old woman who was brought to the the Emergency Room with generalized involuntary movements. She had PD for 12 years, and she was under Carbidopa/L-dopa 250/25mg 4 times daily and Ropinirole 8mg daily, with previous control of her disease. She also had a Major Depressive Disorder, treated with antidepressants. The patient and her companion were both beggars. She presented with generalized choreic-ballistic movements and a mild cognitive impairment. Both patient’s and companion’s information was compatible with DDS and she was admitted for clinical improvement, therapeutic adjustment and social support. She reduced Carbidopa/L-dopa dosage (600mg daily), suspended the dopaminergic agonist and started Clozapine 25mg daily which prevented further abnormal movements and motor fluctuations. During the third week, the dyskinetic choreiform movements suddenly returned and were mainly present from lunch and onward through the afternoon, which did not respect the predictable peak dose neither the end of the dose period that would be expected from the scheduled levodopa intakes. In one situation, her companion was seen administering extra Carbidopa/L-dopa pills, which he referred to be for the patient’s clinical benefit. We were also informed by the Hospital’s Social Service support that the patient’s exuberant choreiform dyskinesia was commonly seen in touristic spots. Her companion’s strategy was to give her excessive doses of Carbidopa/L-dopa which he mixed in a glass of water so as to more rapidly induce the dyskinetic movements, hence increasing their chances of receiving money through begging. The diagnosis of FDIA was then made on the companion.

Conclusion: We presented a new type of DDS in PD, without the addictive dimension usually associated to this syndrome which makes therapeutics and prognosis different.

To cite this abstract in AMA style:

DRC. Carneiro, MS. Sousa, ASM. Morgadinho, CJ. Januário. Factitious Disorder Imposed on Another mimicking a Dopamine Dysregulation Syndrome [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/factitious-disorder-imposed-on-another-mimicking-a-dopamine-dysregulation-syndrome/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/factitious-disorder-imposed-on-another-mimicking-a-dopamine-dysregulation-syndrome/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley